Arterra Bioscience S.p.A. (BIT:ARBS)
Italy
· Delayed Price · Currency is EUR 3.040
+0.080 (2.70%)
Dec 5, 2025, 5:21 PM CET
Arterra Bioscience Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 20 | 13 | 11 | 14 | 19 | 19 | Upgrade
|
| Market Cap Growth | 61.70% | 18.07% | -23.15% | -24.57% | 1.75% | -24.46% | Upgrade
|
| Enterprise Value | 17 | 10 | 6 | 9 | 15 | 15 | Upgrade
|
| Last Close Price | 3.04 | 1.85 | 1.49 | 1.86 | 2.44 | 2.40 | Upgrade
|
| PE Ratio | 15.14 | 9.76 | 10.27 | 10.17 | 17.17 | 16.90 | Upgrade
|
| PS Ratio | 4.85 | 3.13 | 3.31 | 4.01 | 4.02 | 4.49 | Upgrade
|
| PB Ratio | 1.77 | 1.14 | 1.03 | 1.37 | 2.01 | 2.29 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.15 | 1.03 | 1.38 | 2.04 | 2.32 | Upgrade
|
| P/FCF Ratio | 47.79 | 30.81 | 11.52 | 11.06 | 22.28 | 136.05 | Upgrade
|
| P/OCF Ratio | 19.02 | 12.26 | 10.77 | 10.31 | 13.65 | 39.05 | Upgrade
|
| EV/Sales Ratio | 4.13 | 2.39 | 1.67 | 2.64 | 3.20 | 3.63 | Upgrade
|
| EV/EBITDA Ratio | 10.08 | 5.82 | 3.50 | 4.44 | 8.74 | 9.45 | Upgrade
|
| EV/EBIT Ratio | 12.57 | 7.26 | 5.26 | 5.91 | 12.16 | 12.61 | Upgrade
|
| EV/FCF Ratio | 40.74 | 23.53 | 5.80 | 7.27 | 17.73 | 109.95 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.07 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.21 | 0.24 | 0.23 | 0.35 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 0.84 | 0.84 | 0.40 | 0.38 | 0.72 | 5.88 | Upgrade
|
| Asset Turnover | 0.32 | 0.32 | 0.27 | 0.30 | 0.43 | 0.42 | Upgrade
|
| Inventory Turnover | 1.31 | 1.31 | 1.18 | 1.40 | 2.72 | 2.54 | Upgrade
|
| Quick Ratio | 8.44 | 8.44 | 7.74 | 7.48 | 6.51 | 7.02 | Upgrade
|
| Current Ratio | 10.06 | 10.06 | 9.35 | 8.49 | 6.91 | 7.58 | Upgrade
|
| Return on Equity (ROE) | 12.06% | 12.06% | 10.14% | 14.18% | 12.58% | 14.50% | Upgrade
|
| Return on Assets (ROA) | 6.61% | 6.61% | 5.27% | 8.29% | 7.12% | 7.56% | Upgrade
|
| Return on Capital (ROIC) | 7.49% | 7.49% | 5.99% | 9.51% | 8.18% | 8.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.90% | 10.90% | 9.00% | 14.00% | 12.10% | 12.90% | Upgrade
|
| Earnings Yield | 6.60% | 10.24% | 9.74% | 9.83% | 5.83% | 5.92% | Upgrade
|
| FCF Yield | 2.09% | 3.25% | 8.69% | 9.05% | 4.49% | 0.73% | Upgrade
|
| Dividend Yield | 4.28% | 7.02% | 6.71% | 5.38% | 2.05% | - | Upgrade
|
| Payout Ratio | 49.81% | 49.81% | 61.87% | - | - | - | Upgrade
|
| Total Shareholder Return | 4.39% | 7.02% | 6.71% | 5.38% | 2.05% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.